# A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes

> **NCT01473888** · PHASE1 · COMPLETED · sponsor: **Tasly Pharmaceuticals, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Stable Angina

## Interventions

- **DRUG:** T89(Dantonic)

## Key facts

- **NCT ID:** NCT01473888
- **Lead sponsor:** Tasly Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-07
- **Final completion:** 2012-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01473888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01473888, "A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01473888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*